Procurement of cgmp QS21 and production of cgmp ALF55 drug substance
Ended Awarded Last action
- Contract number
- 75N93020F00117
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,782,227
Award facts
- Contract value 100% obligated
- $1,782,227.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,782,227 |
About this award
Advanced Bioscience Laboratories, Inc., doing business as Advanced Bioscience Laboratories Inc., has been awarded a cost-plus-fixed-fee delivery order contract valued at approximately $1.78 million by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, Advanced Bioscience Laboratories will provide cGMP QS21 and produce cGMP ALF55 drug substance in support of the NIH's preclinical development efforts. Work will be performed in Potomac, Maryland through July 2022. No set-aside designation or subcontracting details were provided. This delivery order was issued against an existing NIH vehicle to supply products and services advancing the NIH's mission to expand knowledge and improve public health outcomes in the realm of allergy and infectious disease.
Quick answers
Who was awarded contract 75N93020F00117?
75N93020F00117 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 6, 2020.
How much is contract 75N93020F00117 worth?
The government has obligated $1,782,227 on 75N93020F00117.
Is contract 75N93020F00117 an order under another contract?
Yes. 75N93020F00117 is a delivery order under HHSN272201700010I, an indefinite delivery contract.
Was contract 75N93020F00117 competed?
The extent of competition for 75N93020F00117 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award